临床试验/ISRCTN12767014

ISRCTN12767014已完成未知

Integrated cervical cancer screening in Mayuge district Uganda (ASPIRE Mayuge): a pragmatic cluster randomized control trial

niversity of British Columbia0 个研究点目标入组 2,019 人开始时间: 2019年5月17日最近更新: 2024年6月18日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 2,019

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32005202 protocol (added 03/02/2020) 2022 Preprint results in https://dx.doi.org/10.2139/ssrn.4068261 (added 30/06/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37037880/ (added 11/04/2023) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/36408923/ Participant experiences (added 06/06/2024)

研究设计

研究类型: Interventional

入排标准

性别: Female

入选标准

•1. Women with no previous history of hysterectomy or invasive cervical cancer
•2. Aged 25-49 years old
•3. Not previously been screened and treated for cervical cancer
•4. Provided written informed consent

排除标准

•Do not fulfil inclusion criteria.

研究者

发起方

niversity of British Columbia

相似试验

Validation of a new dental scoring system to assess the junction in the mouth where the gums meet the teethHealthy dentate adult volunteers aged 18 or overOral Health

ISRCTN54471768niversity of Bristol39

进行中（未招募）

Radiotherapy combined with immunotherapy in metastatic non-small cell lung cancer patientsAdvanced non-small cell lung cancer, stage IVMalignant neoplasm the lung, non-small cell lung cancerCancer

ISRCTN49817477Maastricht University88

Comparing different types of jet ventilation during endobronchial ultrasound guided transbronchial needle aspiratioEBUS-TBNA +/- tumour biopsyCancer

ISRCTN58911367Medical University of Vienna90

apatinib plus capecitabine versus continued trastuzumab plus capecitabine after local therapy in patients with ErbB2-positive metastatic breast cancer developing brain metastasis/esBreast cancer, developing brain metastasis/esCancerBreast cancer

ISRCTN58771616eeds Teaching Hospitals NHS Trust (UK)30

Comparing mental well-being of people with hearing loss who have been partnered with a hearing dog to those that have applied for, but not yet received a hearing dogEar, Nose and ThroatHearing loss

ISRCTN36452009niversity of York213